The subsidiary of Ormed Orvax has signed a cooperation agreement with Pharma Corporation from Vietnam, which could sell the vaccine throughout Southeast Asia ■ Orvax’s oral vaccine is in the first phase of human trials in South Africa
You are successfully following Yosef Harash .
You can see updates on new articles on the page My Country
STRINGER / REUTERS Ormed, which is traded in Tel Aviv and NASDAQ and develops drugs for swallowing, has signed a cooperation and sale agreement with the Vietnamese pharma corporation Tan Tan Holdings. Under the agreement, Orvax, Ormed’s subsidiary will sell Tan Tan 10 million oral vaccines to Corona. The agreement includes granting the Vietnamese company the right to market and sell oral vaccines throughout Southeast Asia. Is ORMD-0801 – Insulin capsules for swallowing instead of injections.The company has three versions of the product, in different stages in clinical trials ….
Comments
Skip the comments Main articles on the site